DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
No. FDA removed tirzepatide from the shortage list in October 2024. Some doses (5mg, 7.5mg) still have intermittent regional supply gaps. Check your pharmacy.
No. FDA removed tirzepatide from the shortage list in October 2024. Some doses (5mg, 7.5mg) still have intermittent regional supply gaps. Check your pharmacy.
FDA officially declared the tirzepatide shortage RESOLVED in October 2024. This triggered the 503A compounding wind-down — compounded tirzepatide must cease within 60 days of FDA shortage resolution declaration. Regional supply intermittency persists at some doses (5mg, 7.5mg are most common gaps). If your pharmacy is out, check: another local pharmacy, LillyDirect cash-pay ($549/month maintenance), telehealth compounders before their wind-down deadline. Brand Mounjaro is the most reliable supply path post-shortage.